Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling the practitioner to more quickly and effectively anesthetize patients in certain dental applications. The company also markets and sells: ``SplatrFree(TM)`` disposable prophy angles and related consumable products; and clinically oriented dental products.
Revenue (Most Recent Fiscal Year) | $8.63M |
Net Income (Most Recent Fiscal Year) | $-4.71M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 8.70 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 16.78 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -61.16% |
Net Margin (Trailing 12 Months) | -61.16% |
Return on Equity (Trailing 12 Months) | -82.73% |
Return on Assets (Trailing 12 Months) | -50.09% |
Current Ratio (Most Recent Fiscal Quarter) | 1.94 |
Quick Ratio (Most Recent Fiscal Quarter) | 1.00 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.01 |
Inventory Turnover (Trailing 12 Months) | 0.59 |
Book Value per Share (Most Recent Fiscal Quarter) | $0.06 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | -- |
Diluted Earnings per Share (Trailing 12 Months) | $-0.07 |
Exchange | NYSEMKT |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Common Shares Outstanding | 78.48M |
Free Float | 59.05M |
Market Capitalization | $74.95M |
Average Volume (Last 20 Days) | 0.06M |
Beta (Past 60 Months) | 0.93 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 24.75% |
Percentage Held By Institutions (Latest 13F Reports) | 5.79% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |